--Advertisement--

NCDC: Nigeria records 13,420 cases as meningitis kills 1,069 across 23 states

The Nigeria Centre for Disease Control (NCDS) on Thursday released a situation report on the outbreak of Meningitis in Nigeria.

The report, tweeted via its Twitter handle is titled, “Epidemic Curve of CSM Outbreak in Nigeria as at May 9, 2017.”

According to the report, there are 13,420 reported cases while 1,069 deaths have been recorded.

The report also shows that persons between age 9-12 were more affected while the epidemic took its worst hit between epi- week 14 and 15 of its outbreak.

Advertisement

The report also revealed that 23 states and a total of 211 local government areas have recorded cases of the epidemic, with six states — Zamfara, Sokoto, Kano, Katsina, Kebbi and Yobe — receiving the worst hit.

“From December 13, 2016 to May 8, 2017, 13,420 suspected cases and 1069 deaths (8%) were reported,” the report read.

“Of the 448 laboratory confirmed cases, 293 (65.2%) were Neisseria meningitidis serogroup C.

Advertisement

“In the last four weeks (Epi-week 15-18), 48 Local Government Areas (LGAs) have reached alert/epidemic threshold in six States — Zamfara, Sokoto, Kano, Katsina, Kebbi and Yobe.

“Technical teams still supporting coordination and response activities in the most affected states.

“First batch of medical team deployed to Zamfara and Sokoto States on Saturday, May 6, 2017. The team is supporting case management and surveillance activities in these most affected states.

“Second ICG request for Zamfara state has been approved; delivery of 694,065 polysaccharide vaccine doses expected.

Advertisement

“The government of Nigeria continues to work with global health partners to mobilize additional vaccines, procure laboratory and other supplies to assist with the ongoing response.”

The first case of the epidemic’s outbreak was recorded in Zamfara state.

Abdulaziz Yari, governor of Zmfara state, had said that God sent meningitis to punish Nigerians for their sins.

Advertisement
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected from copying.